SCHEMBL3757634

SCHEMBL3757634

COC(=O)c1c(N2CCOCC2)sc2c1CC(C)(C)CC2=O

nearest known ligand 0.47

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PIK3CD O00329 1/20 0.47
PIK3CA P42336 1/20 0.47
PIK3CB P42338 1/20 0.47
PIK3CG P48736 1/20 0.47
ALDH1A1 P00352 9/20 0.42
SMN1; SMN2 Q16637 2/20 0.42
POLB P06746 2/20 0.39
CNR2 P34972 1/20 0.38
MAPT P10636 1/20 0.37
L3MBTL1 Q9Y468 1/20 0.37
MAPK1 P28482 1/20 0.35
RECQL P46063 1/20 0.35
NPSR1 Q6W5P4 1/20 0.35
BRD4 O60885 1/20 0.35
USP2 O75604 1/20 0.35
KDM4E B2RXH2 1/20 0.35
HSD17B10 Q99714 1/20 0.35
MEN1 O00255 1/20 0.35
KMT2A Q03164 1/20 0.35
GAA P10253 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3766924 0.86 PIK3CD (0.50) PIK3CDPIK3CAPIK3CBPIK3CGALDH1A1
SCHEMBL3760327 0.86 PIK3CA (0.50) PIK3CDPIK3CAPIK3CBPIK3CGALDH1A1
SCHEMBL3759845 0.85 PIK3CA (0.49) PIK3CDPIK3CAPIK3CBPIK3CGALDH1A1
SCHEMBL3763668 0.82 PIK3CA (0.42) PIK3CDPIK3CAPIK3CBPIK3CGALDH1A1
SCHEMBL3756016 0.79 PIK3CD (0.43) PIK3CDPIK3CAPIK3CBPIK3CGALDH1A1
SCHEMBL16161771 0.79 PIK3CD (0.43) PIK3CDPIK3CAPIK3CBPIK3CGALDH1A1
SCHEMBL3764964 0.79 PIK3CA (0.55) PIK3CDPIK3CAPIK3CBPIK3CGALDH1A1
SCHEMBL3758728 0.79 PIK3CA (0.52) PIK3CDPIK3CAPIK3CBPIK3CGALDH1A1
SCHEMBL3766105 0.79 PIK3CA (0.52) PIK3CDPIK3CAPIK3CBPIK3CGALDH1A1
SCHEMBL3764741 0.79 PIK3CA (0.52) PIK3CDPIK3CAPIK3CBPIK3CGALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2029570-B1 FUSED THIOPHENE DERIVATIVES AS KINASE INHIBITORS UCB PHARMA SA (BE) 2014-10-15 EP disclosed
US-8324204-B2 Fused thiophene derivatives as kinase inhibitors UCB PHARMA SA (BE) 2012-12-04 US disclosed
US-20100305066-A1 Fused Thiophene Derivatives as Kinase Inhibitors UCB PHARMA S.A. (BE) 2010-12-02 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100305066-A1 Fused Thiophene Derivatives as Kinase Inhibitors PIKFYVE, PI4KA, PIK3CA PIK3CD 9/4885PIK3CA 3/4885PIK3CB 11/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.